Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats.
about
Soluble epoxide hydrolase: gene structure, expression and deletionCardiovascular disease-related parameters and oxidative stress in SHROB rats, a model for metabolic syndromeEffects of thiazolidinedione therapy on inflammatory markers of type 2 diabetes: a meta-analysis of randomized controlled trialsAnti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.The kidney in obesity.Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.Vascular endothelial over-expression of soluble epoxide hydrolase (Tie2-sEH) enhances adenosine A1 receptor-dependent contraction in mouse mesenteric arteries: role of ATP-sensitive K+ channels.Lipidomic profiling of high-fat diet-induced obesity in mice: Importance of cytochrome P450-derived fatty acid epoxides.Protection of endothelial cells against Ang II-induced impairment: Involvement of both PPARα and PPARγ via PI3K/Akt pathway.Impairment of the Vascular KATP Channel Imposes Fatal Susceptibility to Experimental Diabetes Due to Multi-Organ Injuries.Dietary modulation of oxylipins in cardiovascular disease and aging.Perinatal Inhibition of NF-KappaB Has Long-Term Antihypertensive and Renoprotective Effects in Fawn-Hooded Hypertensive Rats.Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation.Early Postweaning Treatment with Dimethyl Fumarate Prevents Prenatal Dexamethasone- and Postnatal High-Fat Diet-Induced Programmed Hypertension in Male Rat Offspring.
P2860
Q28291292-48E16679-2E5F-4971-A9FF-E09BF65D5DD5Q28541804-87D1867B-17B3-45BC-B172-74FC0A990100Q35510830-2577D96C-D427-40D0-BAA1-AD4E6BE15D97Q37170684-C87C052C-6C15-4C99-A4E8-C9D2FC46C332Q38429861-4E1EEA27-27D9-4D39-BA6D-A786F19FCBDAQ39195631-3EA4F140-12A9-4A15-B0E0-F391975A8D19Q39388975-A906D562-00AE-4DA1-8361-A0959CE8E524Q39788692-B50050EB-D701-4072-9E22-11450BD1EC7DQ40572573-FCC60E01-479B-4BD4-888B-7F64F68C48D8Q46751044-7AC66F59-3154-4005-B4E2-1A244610591AQ48157381-F9559E58-D4C2-4DB7-8E76-59A4007AE074Q50587701-7C2C69D2-26C1-419D-8041-6BA83DC994B4Q53069744-DED7F3C4-4B25-4A8F-B916-CDF6DFD1A9CAQ55004979-EEA44B88-15CB-4A1E-BC15-A0F3CA762D3E
P2860
Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Soluble epoxide hydrolase inhi ...... ry in hypertensive obese rats.
@ast
Soluble epoxide hydrolase inhi ...... ry in hypertensive obese rats.
@en
type
label
Soluble epoxide hydrolase inhi ...... ry in hypertensive obese rats.
@ast
Soluble epoxide hydrolase inhi ...... ry in hypertensive obese rats.
@en
prefLabel
Soluble epoxide hydrolase inhi ...... ry in hypertensive obese rats.
@ast
Soluble epoxide hydrolase inhi ...... ry in hypertensive obese rats.
@en
P2093
P2860
P356
P1476
Soluble epoxide hydrolase inhi ...... ry in hypertensive obese rats.
@en
P2093
Bruce D Hammock
John D Imig
Katie A Walsh
Mary Cherian-Shaw
Md Abdul Hye Khan
Sean M Shaw
Tasuku Nagasawa
P2860
P304
P356
10.1258/EBM.2012.012225
P577
2012-12-01T00:00:00Z